Showing results (1681-1690 of 2,364) with videos related to

Sort By:
Pageof 237
JACC. Cardiovascular Interventions|January 15, 2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsAdriano Caixeta, Alexandra J Lansky, Patrick W Serruys, et al.
Journal of the American College of Cardiology|February 15, 2005
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarctionAbhiram Prasad, Gregg W Stone, Thomas D Stuckey, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial InfarctionXiaolin Zhang, Minghui Cheng, Naijing Gao, et al.
JACC. Cardiovascular Interventions|July 25, 2009
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky, Roxana Mehran, H Mehrdad Sadeghi, et al.
Circulation|August 16, 2020
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-AnalysisSafi U Khan, Maninder Singh, Shahul Valavoor, et al.
The American Journal of Cardiology|February 15, 2014
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)George D Dangas, Annapoorna S Kini, Samin K Sharma, et al.
Journal of Cardiology|January 28, 2014
Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stentsShigeru Saito, Nobuhisa Hagiwara, Atsushi Seki, et al.
The American Journal of Cardiology|August 30, 2011
Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodulesJin-Bae Lee, Gary S Mintz, Jennifer B Lisauskas, et al.
Journal of the American College of Cardiology|March 31, 2007
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY TrialSteven V Manoukian, Frederick Feit, Roxana Mehran, et al.
The American Journal of Cardiology|May 9, 2006
Procedural implications of intravascular ultrasound morphologic features of chronic total coronary occlusionsKenichi Fujii, Masahiko Ochiai, Gary S Mintz, et al.
Pageof 237